World's Best Scientists 2026 revealed!
Vivek Naranbhai

Vivek Naranbhai

D-Index & Metrics

Immunology

D-Index
44
Citations
10419
World Ranking
4754
National Ranking
209

Overview

Vivek Naranbhai is affiliated with Monash University in Australia and primarily conducts research in the field of Medicine. Their subfields of study include Infectious Diseases, Oncology, Immunology, Molecular Biology, and Pulmonary and Respiratory Medicine.

The scientist's research focuses on several main topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Tuberculosis Research and Epidemiology
  • Immunotherapy and Immune Responses
  • Vaccines and Immunoinformatics Approaches

Vivek Naranbhai has contributed research articles in several high-impact and specialized publication venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell
  • Proceedings of the National Academy of Sciences
  • Journal of Investigative Dermatology
  • Journal of Allergy and Clinical Immunology

The scientist has coauthored frequently with the following researchers:

  • A. John Iafrate
  • Alejandro B. Balazs
  • Wilfredo F. García-Beltrán
  • Justin F. Gainor
  • Evan C. Lam

Selected recent publications by Vivek Naranbhai include:

  • "T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals," 2022, published in Cell
  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in Cell
  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in bioRxiv (Cold Spring Harbor Laboratory)

Additional notable papers coauthored by close collaborators include:

  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in Cell
  • "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant," 2022, published in Cell

Best Publications

  • mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

    Unknown

  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression.

    Benjamin P. Fairfax;Peter Humburg;Seiko Makino;Vivek Naranbhai

  • Genital Inflammation and the Risk of HIV Acquisition in Women

    Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  • T-cell activation is an immune correlate of risk in BCG vaccinated infants

    Helen A. Fletcher;Helen A. Fletcher;Margaret A. Snowden;Bernard Landry;Wasima Rida

  • Erratum: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (Cell (2021) 184(9) (2372–2383.e9), (S0092867421002981), (10.1016/j.cell.2021.03.013))

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

    Unknown

  • Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

    Unknown

  • Genomic modulators of gene expression in human neutrophils

    Vivek Naranbhai;Benjamin P. Fairfax;Seiko Makino;Peter Humburg

  • HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.

    Unknown

  • Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

    Vivek Naranbhai;Vivek Naranbhai;Salim S. Abdool Karim;Salim S. Abdool Karim;Marcus Altfeld;Marcus Altfeld;Natasha Samsunder

  • Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells

    Veron Ramsuran;Vivek Naranbhai;Amir Horowitz;Ying Qi

  • Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy

    Vivek. Naranbhai;Adrian V. S. Hill;Adrian V. S. Hill;Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo

  • Germline variants associated with toxicity to immune checkpoint blockade

    Unknown

  • A systematic review of definitions of extreme phenotypes of HIV control and progression.

    Deepti Gurdasani;Louise Iles;David G. Dillon;Elizabeth H. Young

  • Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

    Christina Catherine Chang;Afton A Dorasamy;Bernadett Gosnell;Julian Elliott

  • The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

    Vivek Naranbhai;Vivek Naranbhai;Soyeon Kim;Helen Fletcher;Mark F Cotton

  • Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children

    Anna Rautanen;Matti Pirinen;Tara C Mills;Kirk A Rockett;Kirk A Rockett

  • IFITM3 and Susceptibility to Respiratory Viral Infections in the Community

    Tara C. Mills;Anna Rautanen;Katherine S. Elliott;Tom Parks

  • CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

    Smita Kulkarni;Smita Kulkarni;Alexandra Lied;Viraj Kulkarni;Viraj Kulkarni;Marijana Rucevic

  • The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children

    George M. Warimwe;Linda M. Murungi;Gathoni Kamuyu;George M. Nyangweso

  • Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.

    Vivek Naranbhai;Helen A. Fletcher;Helen A. Fletcher;Rachel Tanner;Matthew K. O'Shea

  • High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.

    Vivek Naranbhai;Christina C Chang;Christina C Chang;Christina C Chang;Wilfredo F Garcia Beltran;Tyler E Miller

  • Changes in Natural Killer cell activation and function during primary HIV-1 Infection.

    Vivek. Naranbhai;Vivek. Naranbhai;Marcus. Altfeld;Marcus. Altfeld;Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Thumbi. Ndung'u;Thumbi. Ndung'u

  • Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.

    Vivek Naranbhai;Vivek Naranbhai;Claire A Pernat;Alexander Gavralidis;Alexander Gavralidis;Kerri J St Denis

  • Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

    Smita Kulkarni;Smita Kulkarni;Alexandra Lied;Viraj Kulkarni;Viraj Kulkarni;Marijana Rucevic

Frequent Co-Authors

Quarraisha Abdool Karim
Quarraisha Abdool Karim Centre for the AIDS Programme of Research in South Africa
Salim S. Abdool Karim
Salim S. Abdool Karim Centre for the AIDS Programme of Research in South Africa
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf
Helen A. Fletcher
Helen A. Fletcher London School of Hygiene & Tropical Medicine
Bruce D. Walker
Bruce D. Walker Harvard University
Helen McShane
Helen McShane University of Oxford
Julian C. Knight
Julian C. Knight University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, various online nursing programs provide flexible pathways into healthcare roles closely tied to immunology research and patient care. Students without a nursing background can explore online RN programs for non nurses, which offer an accessible entry point into the nursing profession while building foundational clinical skills.

For registered nurses aiming to advance quickly, nurse practitioner accelerated program options provide accelerated routes to achieve advanced practice licensure. These programs are ideal for those looking to specialize further, including in areas related to immunology.

Specialized paths such as acute care nurse practitioner programs allow practitioners to hone skills in managing complex, immunology-related conditions in acute and critical care settings. This specialization bridges the gap between immunology knowledge and direct patient intervention.

Additionally, for those seeking the most accessible entry points, the easiest accelerated nursing programs to get into provide practical options to fast-track nursing degrees and begin careers related to immunology support roles without lengthy barriers to entry.

Best Scientists Citing Vivek Naranbhai

Trending Scientists